Melhores Tratamento com células estaminais para cirrose hepática médicos em Turquia - TOP-5 médicos

Education and Specialization

• Ankara University Faculty of Medicine – Medical Education
• Ankara University Faculty of Medicine – General Surgery Specialization
• Akdeniz University Faculty of Medicine – Associate Professorship
• Akdeniz University Faculty of Medicine – Professorship

Professional Memberships
• Turkish Medical Association
• Mediterranean Health Foundation
• Akdeniz University Development and Health Foundation
• Transplantation Organizations Coordination Association
• National Surgical Association

Dr. Seymur Aslanov is a specialist in internal medicine and gastroenterology. He received advanced training at Ege University Faculty of Medicine Hospital. Dr. Aslanov diagnoses and treats many gastrointestinal diseases. His expertise includes inflammatory bowel diseases, digestive system cancers, liver and pancreatic diseases, and gastrointestinal bleeding.

He is skilled in advanced endoscopic procedures. These include ERCP, colonoscopy, endoscopic polypectomy, and stenting for gastrointestinal stenosis. Dr. Aslanov has worked as a research assistant and subspecialist at Ege University. He has also served as an internal medicine specialist at Izmir Medical Point.

He is a member of the Izmir Medical Chamber.

Educação e Especialização

• 1995 – 2001: Licenciatura, Universidade Eskişehir Osmangazi, Faculdade de Medicina, Turquia
• 2001 – 2007: Especialização Médica, Departamento de Medicina Interna, Universidade Akdeniz, Faculdade de Medicina, Turquia
• 2008 – 2011: Subespecialização, Departamento de Medicina Interna, Divisão de Gastroenterologia, Universidade Süleyman Demirel, Faculdade de Medicina, Turquia

Experiência Profissional

• 2001 – 2007: Assistente de Investigação, Departamento de Medicina Interna, Universidade Akdeniz, Faculdade de Medicina
• 2007 – 2008: Especialista em Medicina Interna, Hospital Estatal de Bozkır, Konya
• 2008 – 2011: Assistente de Investigação, Departamento de Gastroenterologia, Universidade Süleyman Demirel, Faculdade de Medicina
• 2011 – 2013: Especialista em Gastroenterologia, Hospital Estatal de Burdur
• 2013 – 2019: Professor Assistente, Departamento de Medicina Interna, Divisão de Gastroenterologia, Universidade Akdeniz, Faculdade de Medicina
• 2019 – 2022: Professor Associado, Departamento de Medicina Interna, Divisão de Gastroenterologia, Universidade Akdeniz, Faculdade de Medicina

Dr. Omer Burcak Binicier is a gastroenterology specialist with strong medical training. He earned his medical degree at Ege University. He completed his internal medicine and gastroenterology specialization at Dokuz Eylül University Faculty of Medicine. Dr. Binicier has over ten years of clinical experience. He has held key positions at SBÜ Tepecik Training and Research Hospital and İzmir Bayraklı City Hospital. He also gained international experience at Korea University.

Dr. Binicier diagnoses and treats a wide range of gastrointestinal diseases. His expertise includes early colon and stomach cancers, inflammatory bowel diseases, liver and pancreatic disorders, and digestive system cancers. He uses advanced endoscopic techniques such as EMR, ESD, ERCP, and endoscopic ultrasound. He is also skilled in minimally invasive obesity treatments. His clinical skills are built on years of hands-on work in top medical centers.

Dr. Cagdas Erdogan is a gastroenterologist at Ankara Etlik City Hospital. He trained in Internal Medicine and Gastroenterology. He earned his MD from Dokuz Eylul University. He completed his Internal Medicine residency from 2014 to 2019. He then completed a Gastroenterology fellowship at Ankara City Hospital from 2019 to 2022. His clinical focus includes advanced endoscopy (ERCP, EUS, EMR, ESD, POEM, EGD, colonoscopy, double-balloon enteroscopy), inflammatory bowel disease, and hepatology.

He has about 40 publications. His work appears in The Turkish Journal of Gastroenterology, Scientific Reports, Endoscopy, and Digestive Diseases and Sciences. Notable studies address vedolizumab in IBD and prophylaxis for post-ERCP pancreatitis. He also reported a 13-year Crohn’s cohort comparing infliximab and adalimumab. Additional work covers outcomes with an adalimumab biosimilar and innovative endoscopic therapies (MCA via double-balloon enteroscopy, holmium laser for Bouveret syndrome, POEM for Zenker’s diverticulum, and ESD for esophageal papillomatosis).